Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Vyloy® (zolbetuximab-clzb)
Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by Astellas for Vyloy® (zolbetuximab-clzb),…
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Syndax Pharmaceuticals for Revuforj® (revumenib),…
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Genentech, a member of the…
CareMed Has Been Selected as a National Specialty Pharmacy Partner for Lecanemab-irmb (Leqembi®)
CareMed, a leading independent Specialty Pharmacy, has been selected by Eisai to be in the pharmacy network for Leqembi® (lecanemab-irmb). Leqembi…
Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by BeiGene for Tevimbra® (tislelizumab), approved…
LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations
Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Johnson & Johnson for LAZCLUZE™ (lazertinib)….
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Servier Pharmaceuticals, as a specialty pharmacy partner for VORANIGO®…
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech, a member of the Roche Group, to be…
Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Ryteloâ„¢ (imetelstat)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Geron Corporation for Ryteloâ„¢ (imetelstat)…
NADONA/LTC Announces the 2024 Stephanie Carroll Memorial Scholarship Recipients Sponsored by PharMerica
The National Association Directors of Nursing Administration in Long-Term Care (NADONA/LTC) announces the winners of its Stephanie Carroll Memorial scholarships….
ÅŒmcare and PharMerica Team Up to Provide the Comprehensive Last Mile Solution to Tackle Medication Non-Adherence
ÅŒmcare today announced that it is collaborating with PharMerica to deliver a comprehensive last mile solution to address medication non-adherence,…
OJEMDAâ„¢ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDAâ„¢…
PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023
Fifty million Americans don’t take their prescribed medication because they can’t afford it, often making the impossible choice between medications…
Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Alexion Pharmaceuticals for Voydeya®…
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)
Onco360®, the nation’s largest independent Oncology Pharmacy, is now the national specialty pharmacy network partner for Karyopharm’s product XPOVIO ®…
PharMerica and NADONA Open Applications for 2024 Annual Stephanie Carroll Memorial Scholarship
PharMerica and the National Association of Directors of Nursing Administration in Long-Term Care (NADONA/LTC) have opened the application portal for…
Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Novartis for Fabhalta® (iptacopan) as…
PharMerica and Independent Living Systems Partner for New Pharmacy to Provide Comprehensive Care, Home Delivery to Miami Area Seniors
Independent Living Systems recently held a ribbon cutting for the first ILS Pharmacy, a new pharmacy solution that provides comprehensive…
TRUQAPâ„¢ (capivasertib) Now Available from Onco360
For the Treatment of Adult Patient with Hormone Receptor (HR)-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced or…
FRUZAQLAâ„¢ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Takeda for Fruzaqlaâ„¢ (fruquintinib). Fruzaqlaâ„¢,…
PharMerica Selects SinguLab to Deliver Pharmacogenomics Solutions for Facilities
SinguLab®, a nationwide provider of precision medicine and diagnostics solutions, today announced a strategic partnership with PharMerica, a large-scale pharmacy…
Axxess and OnePoint Patient Care Announce Product Integration for Pharmacy Benefit Management Services
Axxess and OnePoint Patient Care announced the integration of Axxess Hospice and OnePoint Patient Care’s Pharmacy Benefit Management platform. This…
Advanced Home Infusion Rebrands to Amerita
In 2020, Advanced Home Infusion became a part of Amerita. Since then, we’ve been working to gradually incorporate the Advanced…
PharMerica, NADONA Stephanie Carroll Memorial Scholarship Recipients Announced
The National Association Directors of Nursing Administration in Long-Term Care (NADONA/LTC)Â announced the winners of its Stephanie Carroll Memorial scholarships. The…
PharMerica Donates 820,739 Prescriptions to Underserved Patients in 2022
Partnership Helps Patients in Need Access Necessary Medications to Stay Healthy Nearly 1 in 4 Americans have difficulty affording their…
PharMerica, NADONA Open Applications for Annual Stephanie Carroll Memorial Scholarship
PharMerica and the National Association of Directors of Nursing Administration in Long-Term Care (NADONA/LTC) have opened the application portal for…
PharMerica Selected by New York OGS to Provide Pharmacy Services Throughout all Regions in New York State
PharMerica announced today that it has been awarded a contract, number PC69488, by the New York Office of General Services…
PharMerica Launches Continue Care Transitional Care Management Program
Today, PharMerica launched its Continue Care program to address gaps in care during residents’ transitions from skilled nursing facilities to…
PharMerica’s President Bob Dries Retires
It is with much gratitude that we announce the retirement of Bob Dries, President of PharMerica, for all of the…
PharMerica and Sharps Compliance Partner to Bring MedSafe to Long-Term Care Facilities
PharMerica, a nationwide leader in long-term care (LTC) pharmacy services, is partnering with Sharps Compliance Corp, a nationwide provider of…
PharMerica Team Members Go Above and Beyond During Power Outage
Recently, a PharMerica pharmacy in Warren, Michigan, lost power during a storm, and restoration wasn’t expected until later that evening.